Xtant Medical Holdings Inc
F:XMS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Xtant Medical Holdings Inc
F:XMS
|
US |
|
Hudson Pacific Properties Inc
F:HP9
|
US |
|
B
|
Brighthouse Financial Inc
F:BROC
|
US |
|
C
|
Chalice Mining Ltd
XMUN:C8U
|
AU |
Wall St Price Targets
XMS Price Targets Summary
Xtant Medical Holdings Inc
According to Wall Street analysts, the average 1-year price target for XMS is 2.099 EUR with a low forecast of 1.847 EUR and a high forecast of 2.4 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is XMS's stock price target?
Price Target
2.099
EUR
According to Wall Street analysts, the average 1-year price target for XMS is 2.099 EUR with a low forecast of 1.847 EUR and a high forecast of 2.4 EUR.
What is the Revenue forecast for Xtant Medical Holdings Inc?
Projected CAGR
3%
Over the last 13 years, the compound annual growth rate for Revenue has been 11%. The projected CAGR for the next 6 years is 3%.
What is the Gross Profit forecast for Xtant Medical Holdings Inc?
Projected CAGR
5%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 11%. The projected CAGR for the next 6 years is 5%.
What is the Operating Income forecast for Xtant Medical Holdings Inc?
Projected CAGR
36%
The compound annual growth rate for Operating Income over the next 6 years is 36%.
What is the Pre-Tax Income forecast for Xtant Medical Holdings Inc?
Projected CAGR
-27%
The compound annual growth rate for Pre-Tax Income over the next 3 years is -27%.
What is the Net Income forecast for Xtant Medical Holdings Inc?
Projected CAGR
42%
The compound annual growth rate for Net Income over the next 6 years is 42%.
